My Mission
BioPolicy exists because the biology of disease and the policy that governs who can access treatment for it are almost never taught, or built, together. My academic passions sit at that intersection — neuroscience and cell biology on one side, public policy, humanitarian rights, and socioeconomic inequality on the other. Through my school's biology research program, I study the breast cancer microbiome, using computational analysis of genomic and spatial data to understand how microbial signals and immune cells interact within tumors — work that has shown me just how much biological complexity determines who a treatment actually helps.
That question follows me outside the lab too: watching my grandmother navigate a cancer diagnosis, and my grandfather build a pediatric practice around treating patients regardless of their ability to pay, taught me early that a scientific breakthrough is only as good as the number of people who can reach it. BioPolicy is where I try to hold those two educations together — using what I learn about tumor biology to research, write, and advocate for concrete policy that expands cancer treatment access for low-income families across New York.